Chondrogenesis and developments in our understanding

Current Stem Cell Research and Therapy

Volumn 7, Issue 4, 2012, Pages 243-259

  Mabvuure, Nigel ^a   Hindocha, Sandip ^b   Jordan, Daniel ^c   Khan, Wasim S ^d  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b WHISTON HOSPITAL   (United Kingdom)

^c Countess of Chester Hospital ^*  (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cartilage development; Cartilage tissue engineering; Chondrocyte differentiation; Chondrogenesis; Condensation

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR;

BIOREACTOR; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; EXTRACELLULAR MATRIX; HUMAN; MECHANICAL STRESS; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE ENGINEERING; TRANSCRIPTION REGULATION;

ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CELL ENLARGEMENT; CHONDROCYTES; CHONDROGENESIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS; STEM CELLS; STRESS, PHYSIOLOGICAL; TISSUE ENGINEERING;

EID: 84862632230     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812800793090     Document Type: Review

References (155)

1. Cancedda R, Descalzi Cancedda F, Castagnola P. Chondrocyte differentiation. Int Rev Cytol 1995; 159: 265-358.
2. de Frutos CA, Vega S, Manzanares M, et al. Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. Dev Cell 2007; 13(6): 872-83.
3. Woods A, Wang G, Dupuis H, Shao Z, Beier F. Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis. J Biol Chem 2007; 282(32): 23500-8.
4. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995; 17(12): 1039-48.
5. Chen FH, Rousche KT, Tuan RS. Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2006; 2(7): 373-82.
6. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Research Part C: Embryo Today: Reviews 2005; 75(3): 200-12.
7. van Susante JLC, Pieper J, Buma P, et al. Linkage of chondroitinsulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials 2001; 22(17): 2359-69.
8. Yaylaoglu MB, Yildiz C, Korkusuz F, Hasirci V. A novel osteochondral implant. Biomaterials 1999; 20(16): 1513-20.
9. Watt FM, Dudhia J. Prolonged expression of differentiated phenotype by chondrocytes cultured at low density on a composite substrate of collagen and agarose that restricts cell spreading. Differentiation 1988; 38(2): 140-7.
10. Thomas JT, Grant ME. Cartilage proteoglycan aggregate and fibronectin can modulate the expression of type X collagen by embryonic chick chondrocytes cultured in collagen gels. Biosci Rep 1988; 8(2): 163-71.
11. Mizuno S, Glowacki J. Three-dimensional composite of demineralized bone powder and collagen for in vitro analysis of chondroinduction of human dermal fibroblasts. Biomaterials 1996; 17(18): 1819-25.
12. Taguchi T, Ikoma T, Tanaka J. An improved method to prepare hyaluronic acid and type II collagen composite matrices. J Biomed Mater Res 2002; 61(2): 330-6.
13. Sherwood JK, Riley SL, Palazzolo R, et al. A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials 2002; 23(24): 4739-51.
14. Chen G, Sato T, Ushida T, et al. The use of a novel PLGA fiber/collagen composite web as a scaffold for engineering of articular cartilage tissue with adjustable thickness. J Biomed Mater Res A 2003; 67(4): 1170-80.
15. Ruszymah BH, Chua KH, Mazlyzam AL, Aminuddin BS. Formation of tissue engineered composite construct of cartilage and skin using high density polyethylene as inner scaffold in the shape of human helix. Int J Pediatr Otorhinolaryngol 2011; 75(6): 805-10.
16. Scholten PM, Ng KW, Joh K, et al. A semi-degradable composite scaffold for articular cartilage defects. J Biomed Mater Res A 2011 Feb 9. doi:10.1002/jbm.a.33005. [Epub ahead of print].
17. Zheng X, Yang F, Wang S, et al. Fabrication and cell affinity of biomimetic structured PLGA/articular cartilage ECM composite scaffold. J Mater Sci Mater Med 2011; 22(3): 693-704.
18. Ohyabu Y, Adegawa T, Yoshioka T, et al. A collagen sponge incorporating a hydroxyapatite/chondroitinsulfate composite as a scaffold for cartilage tissue engineering. J Biomater Sci Polym Ed 2009; 20(13): 1861-74.
19. Zhao H, Ma L, Gong Y, Gao C, Shen J. A polylactide/fibrin gel composite scaffold for cartilage tissue engineering: fabrication and an in vitro evaluation. J Mater Sci Mater Med 2009; 20(1): 135-43.
20. Zhao H, Ma L, Gao C, Shen J. A composite scaffold of PLGA microspheres/fibrin gel for cartilage tissue engineering: fabrication, physical properties, and cell responsiveness. J Biomed Mater Res B Appl Biomater 2009; 88(1): 240-9.
21. Hong Y, Gong Y, Gao C, Shen J. Collagen-coated polylactide microcarriers/chitosan hydrogel composite: injectable scaffold for cartilage regeneration. J Biomed Mater Res A 2008; 85(3): 628-37.
22. Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 2007; 6(2): 162-7.
23. Shi D, Cai D, Zhou C. [Fabrication and properties of a composite chitosan/type II collagen scaffold for tissue engineering cartilage]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2005; 19(4): 278-82.
24. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006; 97(1): 33-44.
25. Hall BK, Miyake T. Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int J Dev Biol 1995; 39(6): 881-93.
26. Glenister TW. An embryological view of cartilage. J Anat 1976; 122(Pt 2): 323-30.
27. Hall BK, Miyake T. The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat Embryol (Berl) 1992; 186(2): 107-24.
28. Hall BK, Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000; 22(2): 138-47.
29. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000; 8(5): 309-34.
30. Sandell LJ, Nalin AM, Reife RA. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn 1994; 199(2): 129-40.
31. Widelitz RB, Jiang TX, Murray BA, Chuong CM. Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J Cell Physiol 1993; 156(2): 399-411.
32. Tavella S, Raffo P, Tacchetti C, Cancedda R, Castagnola P. NCAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res 1994; 215(2): 354-62.
33. Delise AM, Tuan RS. Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn 2002; 225(2): 195-204.
34. DeLise AM, Tuan RS. Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem 2002; 87(3): 342-59.
35. Oberlender SA, Tuan RS. Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme. Cell Adhes Commun 1994; 2(6): 521-37.
36. Luo Y, Kostetskii I, Radice GL. N-cadherin is not essential for limb mesenchymal chondrogenesis. Dev Dyn 2005; 232(2): 336-44.
37. Krug D, Bning J, Klinger M, Rohwedel J, Kramer J. Fibronectinintegrin interactions during chondrogenic differentiation of murine embryonic stem cells in vitro. Hum Gene Ther 2009; 20(11): 1498-9.
38. Jami SA, Sepulveda NB, Peters JH. Effect of fibronectin splicing on cell proliferation and chondrocyte-specific gene expression in a mesenchymal stem cell system. Osteoarthritis Cartilage 2010; 18: S234.
39. White DG, Hershey HP, Moss JJ, Daniels H, Tuan RS, Bennett VD. Functional analysis of fibronectin isoforms in chondrogenesis: Full-length recombinant mesenchymal fibronectin reduces spreading and promotes condensation and chondrogenesis of limb mesenchymal cells. Differentiation 2003; 71(4-5): 251-61.
40. Fernandez-Teran M, Bayliss M, Archer CW. Molecular heterogeneity of chondroitin sulphate in the early developing chick wing bud. Anat Embryol (Berl) 1993; 188(2): 189-99.
41. Gould SE, B UW, Kosher RA. Syndecan 3: A member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc Natl Acad Sci USA 1992; 89(8): 3271-5.
42. Seghatoleslami MR, Kosher RA. Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn 1996; 207(1): 114-9.
43. Mackie EJ, Murphy LI. The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc Res Tech 1998; 43(2): 102-10.
44. End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M. Tenascin: a modulator of cell growth. Eur J Biochem 1992; 209(3): 1041-51.
45. Riou JF, Umbhauer M, Shi DL, Boucaut JC. Tenascin: a potential modulator of cell-extracellular matrix interactions during vertebrate embryogenesis. Biol Cell 1992; 75(1): 1-9.
46. Choocheep K, Hatano S, Takagi H, Kimata K, Kongtawelert P, Watanabe H. Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 2010; 285(27): 21114-25.
47. Chimal-Monroy J, Diaz de Leon L. Expression of N-cadherin, NCAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol 1999; 43(1): 59-67.
48. Jiang TX, Yi JR, Ying SY, Chuong CM. Activin enhances chondrogenesis of limb bud cells: stimulation of precartilaginous mesenchymal condensations and expression of NCAM. Dev Biol 1993; 155(2): 545-57.
49. Jin EJ, S PK, Kim D, et al. TGF-beta3 inhibits chondrogenesis by suppressing precartilage condensation through stimulation of Ncadherin shedding and reduction of cRREB-1 expression. Mol Cells 2010; 29(4): 425-32.
50. Hellingman CA, Koevoet W, Kops N, et al. Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development. Tissue Eng Part A 2010; 16(2): 545-56.
51. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, Tabin CJ. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006; 2(12): e216.
52. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. BMP-2enhanced chondrogenesis involves p38 MAPK-mediated downregulation of Wnt-7a pathway. Mol Cells 2006; 22(3): 353-9.
53. Stott NS, Jiang TX, Chuong CM. Successive formative stages of precartilaginous mesenchymal condensations in vitro: modulation of cell adhesion by Wnt-7A and BMP-2. J Cell Physiol 1999; 180(3): 314-24.
54. Pizette S, Niswander L. BMPs are required at two steps of limb chondrogenesis: Formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 2000; 219(2): 237-49.
55. Cameron TL, Belluoccio D, Farlie PG, Brachvogel B, Bateman JF. Global comparative transcriptome analysis of cartilage formation in vivo. BMC Dev Biol 2009; 9: 20.
56. Kronenberg HM, McMahon AP, Tabin CJ. 6 Growth Factors and Chondrogenesis 2009.
57. Smits P, Li P, Mandel J, et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 2001; 1(2): 277-90.
58. Montero JA, Lorda-Diez CI, Hurlé JM. Regenerative medicine and connective tissues: cartilage versus tendon. Journal of Tissue Engineering and Regenerative Medicine. 2011:n/a-n/a.
59. Akiyama H, Lefebvre V. Unraveling the transcriptional regulatory machinery in chondrogenesis. J Bone Miner Metab 2011; 29(4): 390-5.
60. Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994; 79(6): 1111-20.
61. Foster JW, Dominguez-Steglich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994; 372(6506): 525-30.
62. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002; 16(21): 2813-28.
63. Bell DM, Leung KK, Wheatley SC, et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997; 16(2): 174-8.
64. Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 1998; 17(19): 5718-33.
65. Huang W, Zhou X, Lefebvre V, de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocytespecific enhancer. Mol Cell Biol 2000; 20(11): 4149-58.
66. Haudenschild DR, Chen J, Pang N, Lotz MK, D'Lima DD. Rho kinase-dependent activation of SOX9 in chondrocytes. Arthritis Rheum 2010; 62(1): 191-200.
67. Danisovic L, Varga I, Polak S. Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell 2012; 44(2): 69-73.
68. Pizette S, Niswander L. BMPs Are Required at Two Steps of Limb Chondrogenesis: Formation of Prechondrogenic Condensations and Their Differentiation into Chondrocytes. Dev Biol 2000; 219(2): 237-49.
69. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008; 2(2-3): 81-96.
70. Duprez DM, Coltey M, Amthor H, Brickell PM, Tickle C. Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev Biol 1996; 174(2): 448-52.
71. Keller B, Yang T, Chen Y, et al. Interaction of TGFbeta and BMP signaling pathways during chondrogenesis. PLoS One 2011; 6(1): e16421.
72. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREBbinding protein/p300 recruitment. J Biol Chem 2005; 280(9): 8343-50.
73. Lee YS, Chuong CM. Activation of protein kinase A is a pivotal step involved in both BMP-2and cyclic AMP-induced chondrogenesis. J Cell Physiol 1997; 170(2): 153-65.
74. Liu W, Oh SH, Kang Yk Y, et al. Bone morphogenetic protein 4 (BMP4): a regulator of capsule chondrogenesis in the developing mouse inner ear. Dev Dyn 2003; 226(3): 427-38.
75. Horiguchi M, Akiyama H, Ito H, Shigeno C, Nakamura T. Tumour necrosis factor-alpha up-regulates the expression of BMP-4 mRNA but inhibits chondrogenesis in mouse clonal chondrogenic EC cells, ATDC5. Cytokine 2000; 12(5): 526-30.
76. Demirhan O, Turkmen S, Schwabe GC, et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet 2005; 42(4): 314-7.
77. Francis-West PH, Abdelfattah A, Chen P, et al. Mechanisms of GDF-5 action during skeletal development. Development 1999; 126(6): 1305-15.
78. Buxton P, Edwards C, Archer CW, Francis-West P. Growth/differentiation factor-5 (GDF-5) and skeletal development. J Bone Joint Surg Am 2001; 83-A Suppl 1(Pt 1): S23-30.
79. Kou I, Ikegawa S. SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J Biol Chem 2004; 279(49): 50942-8.
80. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 1999; 250(2): 351-63.
81. Elkasrawy M, Fulzele S, Bowser M, Wenger K, Hamrick M. Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression. Growth Factors 2011; 29(6): 253-62.
82. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006; 14(5): 403-12.
83. Oh CD, Chun JS. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem 2003; 278(38): 36563-71.
84. Nakajima M, Negishi Y, Tanaka H, Kawashima K. p21(Cip-1/SDI1/WAF-1) expression via the mitogen-activated protein kinase signaling pathway in insulin-induced chondrogenic differentiation of ATDC5 cells. Biochem Biophys Res Commun 2004; 320(4): 1069-75.
85. Fukumoto T, Sperling JW, Sanyal A, et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003; 11(1): 55-64.
86. Palmer GD, Steinert A, Pascher A, et al. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 2005; 12(2): 219-28.
87. Madry H, Orth P, Kaul G, et al. Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo. Arch Orthop Trauma Surg 2010; 130(10): 1311-22.
88. Patil AS, Sable RB, Kothari RM. Role of insulin-like growth factors (IGFs), their receptors and genetic regulation in the chondrogenesis and growth of the mandibular condylar cartilage. J Cell Physiol 2012; 227(5): 1796-804.
89. Szebenyi G, Savage MP, Olwin BB, Fallon JF. Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning. Dev Dyn 1995; 204(4): 446-56.
90. Liu Z, Xu J, Colvin JS, Ornitz DM. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002; 16(7): 859-69.
91. Mugniery E, Dacquin R, Marty C, et al. Impact of activating fibroblast growth factor receptor 3 mutation in endochondral ossification. Bone 2011; 48: S67.
92. Sawaji Y, Hynes J, Vincent T, Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008; 58(11): 3498-509.
93. Handorf AM, Li WJ. Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis. PLoS One 2011; 6(7): e22887.
94. Hildner F, Peterbauer A, Wolbank S, et al. FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGF-beta in human adipose derived stem cells. J Biomed Mater Res A 2010; 94(3): 978-87.
95. Ohbayashi N, Shibayama M, Kurotaki Y, et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002; 16(7): 870-9.
96. Davidson D, Blanc A, Filion D, et al. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 2005; 280(21): 20509-15.
97. Liu Z, Lavine KJ, Hung IH, Ornitz DM. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol 2007; 302(1): 80-91.
98. Reinhold MI, Abe M, Kapadia RM, Liao Z, Naski MC. FGF18 represses noggin expression and is induced by calcineurin. J Biol Chem 2004; 279(37): 38209-19.
99. Moore EE, Bendele AM, Thompson DL, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 2005; 13(7): 623-31.
100. Correa D, Rom E, Welter JF, Duesler L, Yayon A, Caplan AI. Fibroblast growth factors 18 and 9 regulate chondrogenic differentiation of human mesenchymal stem cells. Osteoarthritis and Cartilage 2011; 19: S29.
101. Smits P, Dy P, Mitra S, Lefebvre V. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 2004; 164(5): 747-58.
102. Takeda S, Bonnamy J-P, Owen MJ, Ducy P, Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes & Development 2001; 15(4): 467-81.
103. Akiyama H, Lyons JP, Mori-Akiyama Y, et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004; 18(9): 1072-87.
104. Bi W, Huang W, Whitworth DJ, et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA. 2001; 98(12): 6698-703.
105. Zhang M, Xie R, Hou W, et al. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation. J Cell Sci 2009; 122(Pt 9): 1382-9.
106. Bradley EW, Drissi MH. WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol Endocrinol 2010; 24(8): 1581-93.
107. Dong YF, Soung DY, Schwarz EM, O'Keefe RJ, Drissi H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 2006; 208(1): 77-86.
108. Yamashita S, Andoh M, Ueno-Kudoh H, Sato T, Miyaki S, Asahara H. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 2009; 315(13): 2231-40.
109. Wei L, Kanbe K, Lee M, et al. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 2010; 341(1): 236-45.
110. Welting TJ, Coolsen MM, Caron MM, et al. Decreased chondrocyte hypertrophic differentiation by inhibition of Cyclooxygenase-2. Osteoarthritis and Cartilage 2009; 17: S103.
111. Vega RB, Matsuda K, Oh J, et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119(4): 555-66.
112. Provot S, Kempf H, Murtaugh LC, et al. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 2006; 133(4): 651-62.
113. Harrington EK, Lunsford LE, Svoboda KK. Chondrocyte terminal differentiation, apoptosis, and type X collagen expression are downregulated by parathyroid hormone. Anat Rec Part A Discov Mol Cell Evol Biol 2004; 281(2): 1286-95.
114. Horton WA, S TR. International workshop on the Skeletal Growth Plate Stevenson, Washington, June 11-15, 2006. Matrix Biology 2007; 26(4): 324-9.
115. Li Y, Ahrens MJ, Wu A, Liu J, Dudley AT. Calcium/calmodulindependent protein kinase II activity regulates the proliferative potential of growth plate chondrocytes. Development 2011; 138(2): 359-70.
116. Cailotto F, Lories RJ. GPR22 overexpression alters the course of chondrogenesis towards chondrocyte hypertrophy and matrix mineralization: A possible link to osteoarthritis? Osteoarthritis and Cartilage 2011; 19: S99-S100.
117. Ono K, Hata K, Nakamura E, et al. Transcription factor Dmrt2 (double-sex and mab-3 related transcription factor 2) controls endochondral ossification by inhibiting early chondrogenesis and promoting late chondrogenesis. Bone 2009; 44: S346.
118. Adams CS, Shapiro IM. The fate of the terminally differentiated chondrocyte: evidence for microenvironmental regulation of chondrocyte apoptosis. Crit Rev Oral Biol Med 2002; 13(6): 465-73.
119. James CG, Woods A, Underhill TM, Beier F. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. BMC Mol Biol URL http://wwwbiomedcentralcom/1471-2199/7/30.200619Sep;7.
120. Sato M, Morii E, Komori T, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998; 17(12): 1517-25.
121. Kita K, Kimura T, Nakamura N, Yoshikawa H, Nakano T. PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation. Genes to Cells 2008; 13(8): 839-50.
122. MacLean HE, Kim JI, Glimcher MJ, Wang J, Kronenberg HM, Glimcher LH. Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev Biol 2003; 262(1): 51-63.
123. Li T, Xiao J, Wu Z, Qui G. Over-expression of c-maf by chondrocytes in osteoarthritis. J Int Med Res 2009; 37(1): 129-35.
124. Li T, Xiao J, Wu Z, Qiu G, Ding Y. Transcriptional activation of human MMP-13 gene expression by c-Maf in osteoarthritic chondrocyte. Connect Tissue Res 2010; 51(1): 48-54.
125. Zhang X, Ziran N, Goater JJ, et al. Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 2004; 34(5): 809-17.
126. Mueller MB, Fischer M, Zellner J, et al. Hypertrophy in mesenchymal stem cell chondrogenesis: Effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 2010; 192(3): 158-66.
127. Wang L, Shao YY, Ballock RT. Thyroid hormone interacts with the Wnt/beta-catenin signaling pathway in the terminal differentiation of growth plate chondrocytes. J Bone Miner Res 2007; 22(12): 1988-95.
128. Zuscik MJ, Hilton MJ, Zhang X, Chen D, O'Keefe RJ. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 2008; 118(2): 429-38.
129. Yu B, Yu D, Cao L, et al. Simulated microgravity using a rotary cell culture system promotes chondrogenesis of human adiposederived mesenchymal stem cells via the p38 MAPK pathway. Biochem Biophys Res Commun 2011; 414(2): 412-8.
130. Sheehy EJ, Buckley CT, Kelly DJ. Chondrocytes and bone marrow-derived mesenchymal stem cells undergoing chondrogenesis in agarose hydrogels of solid and channelled architectures respond differentially to dynamic culture conditions. J Tissue Eng Regen Med 2011; 5(9): 747-58.
131. Tarng YW, Huang BF, Su FC. A novel recirculating flow-perfusion bioreactor for periosteal chondrogenesis. Int Orthop 2012; 36(4): 863-8.
132. Sheehy EJ, Buckley CT, Kelly DJ. Chondrocytes and bone marrow-derived mesenchymal stem cells undergoing chondrogenesis in agarose hydrogels of solid and channelled architectures respond differentially to dynamic culture conditions. J Tissue Eng Regen Med 2011; 5(9): 747-58.
133. Tigli RS, Cannizaro C, Gumusderelioglu M, Kaplan DL. Chondrogenesis in perfusion bioreactors using porous silk scaffolds and hESC-derived MSCs. J Biomed Mater Res A 2011; 96(1): 21-8.
134. Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ. Mechanical load modulates chondrogenesis of human mesenchymal stem cells through the TGF-beta pathway. J Cell Mol Med 2010; 14(6A): 1338-46.
135. Thorpe SD, Buckley CT, Vinardell T, O'Brien FJ, Campbell VA, Kelly DJ. Dynamic compression can inhibit chondrogenesis of mesenchymal stem cells. Biochem Biophys Res Commun 2008; 377(2): 458-62.
136. Freed LE, Hollander AP, Martin I, Barry JR, Langer R, VunjakNovakovic G. Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res 1998; 240(1): 58-65.
137. Li Z, Yao S-J, Alini M, Stoddart MJ. Chondrogenesis of Human Bone Marrow Mesenchymal Stem Cells in Fibrin-Polyurethane Composites Is Modulated by Frequency and Amplitude of Dynamic Compression and Shear Stress. Tissue Engineering Part A 2010; 16(2): 575-84.
138. Liu TY, Zhou GD, Miao CL, et al. [Influence of mechanical stress on chondrogenesis of in vitro cultured porcine bone marrow stem cells: a preliminary study]. Zhonghua Yi Xue Za Zhi 2004; 84(23): 1997-2001.
139. Schatti O, Grad S, Goldhahn J, et al. A combination of shear and dynamic compression leads to mechanically induced chondrogenesis of human mesenchymal stem cells. Eur Cell Mater 2011; 22: 214-25.
140. Thorpe SD, Buckley CT, Vinardell T, O'Brien FJ, Campbell VA, Kelly DJ. The response of bone marrow-derived mesenchymal stem cells to dynamic compression following TGF-beta3 induced chondrogenic differentiation. Ann Biomed Eng 2010; 38(9): 2896-909.
141. Li Z, Yao SJ, Alini M, Stoddart MJ. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Eng Part A 2010; 16(2): 575-84.
142. Huang AH, Farrell MJ, Kim M, Mauck RL. Long-term dynamic loading improves the mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogel. Eur Cell Mater 2010; 19: 72-85.
143. Kisiday JD, Frisbie DD, McIlwraith CW, Grodzinsky AJ. Dynamic compression stimulates proteoglycan synthesis by mesenchymal stem cells in the absence of chondrogenic cytokines. Tissue Eng Part A 2009; 15(10): 2817-24.
144. Jung Y, Kim SH, Kim YH. The effects of dynamic and threedimensional environments on chondrogenic differentiation of bone marrow stromal cells. Biomed Mater 2009; 4(5): 055009.
145. 2+] and pH. Histol Histopathol 1998; 13(3): 893-910.
146. Lagana K, Moretti M, Dubini G, Raimondi MT. A new bioreactor for the controlled application of complex mechanical stimuli for cartilage tissue engineering. Proc Inst Mech Eng H 2008 Jul; 222(5): 705-15.
147. Provot S, Zinyk D, Gunes Y, et al. Hif-1 regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 2007; 177(3): 451-64.
148. Schipani E. Hypoxia and HIF-1 alpha in chondrogenesis. Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):539-46.
149. Robins JC, Akeno N, Mukherjee A, et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 2005; 37(3): 313-22.
150. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E. HIF1 regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 2007; 134(21): 3917-28.
151. Kawato Y, Hirao M, Ebina K, et al. Nkx3.2-induced suppression of Runx2 is a crucial mediator of hypoxia-dependent maintenance of chondrocyte phenotypes. Biochemical and Biophysical Research Communications 2011; 416(1-2): 205-10.
152. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001; 15(21): 2865-76.
153. Henn RF, Gomoll AH. A review of the evaluation and management of cartilage defects in the knee. Phys Sportsmed 2011; 39(1): 101-7.
154. Mahmoudifar N, Doran PM. Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol 2012; 30(3): 166-76.
155. Pelttari K, Steck E, Richter W. The use of mesenchymal stem cells for chondrogenesis. Injury 2008; 39 Suppl 1: S58-65.